244 related articles for article (PubMed ID: 32458997)
21. Exploring the surface epitope and nuclear localization analysis of porcine circovirus type 3 capsid protein.
Chang CC; Wu CY; Ciou JG; Wu CW; Wang YC; Chang HW; Chien MS; Huang C
AMB Express; 2023 Dec; 13(1):141. PubMed ID: 38066347
[TBL] [Abstract][Full Text] [Related]
22. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
23. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
Bandrick M; Gutiérrez AH; Desai P; Rincon G; Martin WD; Terry FE; De Groot AS; Foss DL
Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900
[TBL] [Abstract][Full Text] [Related]
24. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
[TBL] [Abstract][Full Text] [Related]
25. A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate.
Lamazares E; Gutiérrez F; Hidalgo A; Gutiérrez NA; Espinoza FI; Sánchez O; Cortez-San Martín M; Mascayano C; González J; Saavedra J; Altamirano C; Mansur M; Ruiz Á; Toledo JR
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244384
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
[TBL] [Abstract][Full Text] [Related]
27. Production of a monoclonal antibody against Porcine circovirus type 3 cap protein.
Li X; Bai Y; Zhang H; Zheng D; Wang T; Wang Y; Deng J; Sun Z; Tian K
J Virol Methods; 2018 Nov; 261():10-13. PubMed ID: 30063907
[TBL] [Abstract][Full Text] [Related]
28. Expression, purification and antibody preparation using different constructs of PCV2 capsid protein.
Chen F; Yang X; Pang D; Peng Z; Dong M; Liu X; Ouyang H; Ren L
Int J Biol Macromol; 2014 Jun; 67():289-94. PubMed ID: 24690536
[TBL] [Abstract][Full Text] [Related]
29. High-level expression and immunogenicity of porcine circovirus type 2b capsid protein without nuclear localization signal expressed in Hansenula polymorpha.
Xiao Y; Zhao P; Du J; Li X; Lu W; Hao X; Dong B; Yu Y; Wang L
Biologicals; 2018 Jan; 51():18-24. PubMed ID: 29225046
[TBL] [Abstract][Full Text] [Related]
30. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2.
Shang SB; Jin YL; Jiang XT; Zhou JY; Zhang X; Xing G; He JL; Yan Y
Mol Immunol; 2009 Jan; 46(3):327-34. PubMed ID: 19059648
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection.
Cao X; Huang M; Wang Y; Chen Y; Yang H; Quan F
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373524
[TBL] [Abstract][Full Text] [Related]
32. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
[TBL] [Abstract][Full Text] [Related]
33. Does porcine circovirus type 3 (PCV3) interfere with porcine circovirus type 2 (PCV2) vaccine efficacy?
Woźniak A; Miłek D; Bąska P; Stadejek T
Transbound Emerg Dis; 2019 Jul; 66(4):1454-1461. PubMed ID: 31059197
[TBL] [Abstract][Full Text] [Related]
34. Genetic diversity and prevalence of porcine circovirus type 3 (PCV3) and type 2 (PCV2) in the Midwest of the USA during 2016-2018.
Wang Y; Noll L; Lu N; Porter E; Stoy C; Zheng W; Liu X; Peddireddi L; Niederwerder M; Bai J
Transbound Emerg Dis; 2020 May; 67(3):1284-1294. PubMed ID: 31886622
[TBL] [Abstract][Full Text] [Related]
35. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
[TBL] [Abstract][Full Text] [Related]
36. Production of Escherichia coli-based virus-like particle vaccine against porcine circovirus type 2 challenge in piglets: Structure characterization and protective efficacy validation.
Xi X; Mo X; Xiao Y; Yin B; Lv C; Wang Y; Sun Z; Yang Q; Yao Y; Xuan Y; Li X; Yuan YA; Tian K
J Biotechnol; 2016 Apr; 223():8-12. PubMed ID: 26907669
[TBL] [Abstract][Full Text] [Related]
37. Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine.
Yu C; Li X; Liu J; Diao W; Zhang L; Xiao Y; Wei H; Yu Y; Yu Y; Wang L
Vaccine; 2016 Dec; 34(50):6358-6366. PubMed ID: 27817956
[TBL] [Abstract][Full Text] [Related]
38. Carboxyl-Terminal Decoy Epitopes in the Capsid Protein of Porcine Circovirus Type 2 Are Immunogenicity-Enhancers That Elicit Predominantly Specific Antibodies in Non-Vaccinated Pigs.
Hung LC
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366471
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
40. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
